Litcius/Paper detail

Fibroblast growth factor 23 decreases PDE4 expression in heart increasing the risk of cardiac arrhythmia; Klotho opposes these effects

Marta Lindner, Hind Mehel, Amandine David, Christine Leroy, Martine Burtin, Gérard Friedlander, Fabiola Terzi, Delphine Mika, Rodolphe Fischmeister, Dominique Prié

2020Basic Research in Cardiology30 citationsDOI

Topics & Concepts

PhospholambanInternal medicineEndocrinologyRyanodine receptor 2KlothoFibroblast growth factor 23Heart failureRyanodine receptorMedicineSERCAHeart diseaseKidney diseaseCardiologyCalciumKidneyChemistryParathyroid hormoneBiochemistryEnzymeATPaseParathyroid Disorders and TreatmentsMagnesium in Health and DiseaseGenetic Syndromes and Imprinting
Fibroblast growth factor 23 decreases PDE4 expression in heart increasing the risk of cardiac arrhythmia; Klotho opposes these effects | Litcius